Tridecactide

DB15687InvestigationalSmall molecule

Tridecactide is an investigational modified alpha melanocyte stimulating hormone being studied for the treatment of COVID-19. Tridecactide, also known as alpha-corticotropin 1-13, is a deacetylated and deaminated alpha-melanocyte stimulating hormone, which may have antipyretic, anti-inflammatory, and antimicrobial effects.

Formula / weight: C₇₅H₁₀₆N₂₀O₁₉S · 1623.85 g/mol (avg)
Also known as: alpha-1-13-corticotropin, human

Resolves to

Compound

UNIIT7PQK27HTICAS22006-64-0

Structure

InChIKeyVGBVAARMQYYITG-DESRROFGSA-NSMILES

CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O

What you can answer from here — as of February 21, 2021

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Tridecactide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account